COMMUNIQUÉS West-GlobeNewswire

Mesa Labs Declares Quarterly Dividend
10/07/2018
Lakewood, Colorado, July 09, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of [...]
Helix BioPharma Corp. Closes Private Placement
09/07/2018
RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Adamas Announces New Employment Inducement Grant
09/07/2018
EMERYVILLE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option [...]
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
09/07/2018
Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a [...]
Actinium to Host Webcast on July 10, 2018 to Discuss Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients
09/07/2018
Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse with a need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM ET to discuss planned trial [...]
T2 Biosystems Reports Granting of Inducement Awards
09/07/2018
LEXINGTON, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Spero Therapeutics Announces Proposed Offering of Common Stock
09/07/2018
CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]
Inspire Medical Systems, Inc. Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
09/07/2018
MINNEAPOLIS, July 09, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
TLC Reports Last Patient Last Visit (LPLV) in TLC599 Phase II Trial and FDA Clearance to Commence New Clinical Trials
09/07/2018
LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) pain Phase II topline results on-track for 2018 release Set to initiate enrollment of US Phase II pharmacokinetic (PK) trial for [...]
EnviroLogix Introduces QuickScan II
09/07/2018
EnviroLogix Inc.'s history as a technology innovator for the global agricultural diagnostic markets continues with the introduction of the next generation QuickScan II instrument for quantitative GMO and mycotoxin [...]
Sanofi: Disclosure of trading in own shares
09/07/2018
Attachment Disclosure of trading in own shares (pdf).pdf
Sanofi : Déclaration des transactions sur actions propres
09/07/2018
Pièce jointe Déclaration des transactions sur actions propres (pdf).pdf
Ossur Hf : Transactions in relation to share buyback program
09/07/2018
Announcement no. 43/2018 Reykjavik, 09 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
09/07/2018
BATON ROUGE, La., July 09, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
New Study Shows Superior Healing Outcomes Associated with Ultrasonic Debridement
09/07/2018
FARMINGDALE, N.Y., July 09, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology
09/07/2018
- Development program to focus on combination of antisense oligonucleotides with Matinas’ Proprietary LNC Delivery Technology - BEDMINSTER, N.J. and WASHINGTON, July 09, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma [...]
100th Surgical Implantation of ZIP ULTRA™ MIS Interspinous Device Performed in Canada
09/07/2018
CARLSBAD, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the 100 th surgical implantation of the company's ZIP ULTRA® minimally invasive [...]
Alphatec to Report Second Quarter 2018 Financial Results on August 2, 2018
09/07/2018
CARLSBAD, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]
United Health Products to Offer Retail Sales of HemoStyp® Products on Walmart.com and Jet.com
09/07/2018
HENDERSON, Nev., July 09, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced [...]

Pages